Promotions & Moves

Syngene Strengthens Leadership Team 

Maninder Kapoor Puri joins as CHRO and Abhijit Zutshi joins as CCO.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has appointed Abhijit Zutshi as Chief Commercial Officer and Maninder Kapoor Puri as Chief Human Resources Officer.

Abhijit (Abhi) will be based in the U.S. As a member of the Executive Committee, Abhi will lead Syngene’s commercial activities, including sales, client partnerships, marketing, brand building, digital initiatives, and account management. He is tasked with further expanding the CRDMO’s pipeline of partners from innovative U.S.-based biotechs and large pharma, as well as significantly deepening existing partnerships as more global customers undertake late-stage development and commercial supply with Syngene. 

Abhi is a seasoned pharmaceutical executive with nearly 27 years of commercial experience across global markets. He spent 25 years at Biocon, most recently as Chief Commercial Officer of the generics business, where he led both the drug substance and drug product divisions and built a global team focused on generic formulations. His career expertise spans sales, marketing, business development, portfolio management, and market entry strategy across small and large molecules. 

Maninder Kapoor Puri is a global HR leader with nearly three decades of experience driving business performance through people, leadership, culture, and digital HR ecosystems. Her experience spans biopharmaceuticals, IT services, and consulting across North America, EMEA, and APAC. She has partnered with CEOs and Boards to lead large-scale, multi-market transformations, building high-performance organizations aligned to business growth.

Most recently, as CHRO at Biocon, she led enterprise-wide culture and leadership transformation. As Chief Human Resources Officer and a member of the Executive Committee at Syngene, Maninder will be leading the company’s global people agenda to support its next phase of growth.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters